PortfoliosLab logo

Apyx Medical Corporation (APYX)

Equity · Currency in USD · Last updated Mar 27, 2023

Share Price Chart


Loading data...

Performance

The chart shows the growth of $10,000 invested in Apyx Medical Corporation in Oct 2022 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $34,353 for a total return of roughly 243.53%. All prices are adjusted for splits and dividends.


100.00%200.00%300.00%400.00%500.00%NovemberDecember2023FebruaryMarch
243.53%
320.56%
APYX (Apyx Medical Corporation)
Benchmark (^GSPC)

S&P 500

Compare to other instruments

Search for stocks, ETFs, and funds to compare with APYX

Apyx Medical Corporation

Return

Apyx Medical Corporation had a return of 24.79% year-to-date (YTD) and -54.16% in the last 12 months. Over the past 10 years, Apyx Medical Corporation had an annualized return of 0.46%, while the S&P 500 had an annualized return of 9.85%, indicating that Apyx Medical Corporation did not perform as well as the benchmark.


PeriodReturnBenchmark
1 month-6.11%-0.66%
Year-To-Date24.79%3.42%
6 months-42.75%5.67%
1 year-54.16%-10.89%
5 years (annualized)-0.47%8.95%
10 years (annualized)0.46%9.85%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
202324.79%11.30%
2022-21.64%11.36%-64.80%32.95%

Sharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Apyx Medical Corporation Sharpe ratio is -0.47. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


-0.90-0.80-0.70-0.60-0.50-0.40-0.30-0.20NovemberDecember2023FebruaryMarch
-0.47
-0.47
APYX (Apyx Medical Corporation)
Benchmark (^GSPC)

Dividend History


Apyx Medical Corporation doesn't pay dividends

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%NovemberDecember2023FebruaryMarch
-83.22%
-17.21%
APYX (Apyx Medical Corporation)
Benchmark (^GSPC)

Worst Drawdowns

The table below shows the maximum drawdowns of the Apyx Medical Corporation. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Apyx Medical Corporation is 91.95%, recorded on Nov 22, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-91.95%Nov 23, 2021252Nov 22, 2022
-83.88%Dec 28, 20062366May 31, 20161166Jan 15, 20213532
-51.47%Nov 17, 2003460Sep 20, 2005153May 1, 2006613
-46.43%Jun 28, 200264Oct 31, 200294May 19, 2003158
-27.78%Dec 26, 200127Feb 20, 200216Mar 19, 200243
-26.83%Aug 2, 200612Aug 17, 200647Oct 24, 200659
-25.57%Mar 12, 202199Aug 2, 202138Sep 24, 2021137
-24%Mar 20, 20024Mar 25, 200212Apr 15, 200216
-23.29%Oct 13, 20034Oct 16, 200320Nov 13, 200324
-22.68%Oct 25, 20066Nov 1, 200625Dec 7, 200631

Volatility Chart

Current Apyx Medical Corporation volatility is 118.89%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


0.00%100.00%200.00%300.00%400.00%500.00%NovemberDecember2023FebruaryMarch
118.89%
19.50%
APYX (Apyx Medical Corporation)
Benchmark (^GSPC)